Iceland Press Releases

Published on July 3, 2023 - 21:31 GMT

Aztiq과 Innobic, AEMH가 보유한 Lotus 보통주 2차 공모 가격 발표

런던/태국 방콕, July 04, 2023 (GLOBE NEWSWIRE) -- 생명과학 분야에 중점을 둔 사모펀드 운용사인 Aztiq Pharma Partners는 오늘 태국 석유 가스 대기업 PTT Public Company Limited의 생명과학 부문 자회사인 Innobic (Asia) Company Limited와 공동으로 다국적 제약사인 Lotus Pharmaceuticals (1795:TT)의 주식 25,095,850주를 주당 NT$297에 …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on July 3, 2023 - 21:31 GMT

Aztiq dan Innobic Umumkan Harga Jualan Sekunder Saham Biasa Lotus oleh AEMH

LONDON dan BANGKOK, Thailand, July 04, 2023 (GLOBE NEWSWIRE) -- Aztiq Pharma Partners (“Aztiq”), sebuah syarikat ekuiti swasta yang memfokus kepada sektor sains hayat, dan Innobic (Asia) Company Limited (“Innobic”), cabang sains hayat konglomerat minyak …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on July 3, 2023 - 21:31 GMT

Aztiq e Innobic anunciam preço da venda secundária de ações ordinárias da Lotus pela AEMH

LONDRES e BANGKOK, Tailândia, July 03, 2023 (GLOBE NEWSWIRE) -- A Aztiq Pharma Partners ("Aztiq"), uma empresa de private equity focada no setor de ciências da vida, e a Innobic (Asia) Company Limited ("Innobic"), o braço de ciências da …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on July 3, 2023 - 21:31 GMT

Aztiq และ Innobic ประกาศราคาขายรองของหุ้นสามัญของ Lotus โดย AEMH

ลอนดอนและกรุงเทพมหานคร ประเทศไทย, July 04, 2023 (GLOBE NEWSWIRE) -- Aztiq Pharma Partners (“Aztiq”) บริษัทเอกชนซึ่งมุ่งเน้นไปที่ภาควิทยาศาสตร์เพื่อชีวิตและบริษัท Innobic (Asia) Company Limited (“Innobic”) …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on July 3, 2023 - 21:31 GMT

Aztiq和Innobic宣布AEMH二次出售Lotus普通股的定价

伦敦和泰国曼谷, July 04, 2023 (GLOBE NEWSWIRE) -- 专注于生命科学领域的私募公司Aztiq Pharma Partners（“Aztiq”）及泰国石油天然气集团PTT Public Company Limited（“PTT”）的生命科学事业部Innobic (Asia) Company Limited（“Innobic”）（合称“股东”）今日宣布，以每股新台币297元的价格出售25,095,850股跨国制药公司Lotus Pharmaceuticals（1795：TT；“ …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on July 3, 2023 - 21:31 GMT

Aztiq與Innobic宣佈AEMH二次出售Lotus普通股的定價

倫敦和泰國曼谷, July 04, 2023 (GLOBE NEWSWIRE) -- Aztiq Pharma Partners（「Aztiq」)是一家專注於生命科學行業的私募股權公司，其與泰國石油和天然氣企業集團PTT Public Company Limited（「PTT」）的生命科學業務分支Innobic (Asia) Company Limited（「Innobic」）（統稱「股東」）今日宣佈出售跨國製藥公司Lotus Pharmaceuticals（1795:TT；「Lotus」、「公司」）25, …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on July 3, 2023 - 01:15 GMT

Aztiq and Innobic Announce Pricing of Secondary Sale of Lotus Common Stock by AEMH

LONDON and BANGKOK, Thailand, July 03, 2023 (GLOBE NEWSWIRE) -- Aztiq Pharma Partners (“Aztiq”), a private equity company focused on the life sciences sector, and Innobic (Asia) Company Limited (“Innobic”), the life science arm of Thai oil and gas …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on June 28, 2023 - 23:00 GMT

Alvotech Provides Regulatory Update on Second Biologics License Application for AVT02

REYKJAVIK, Iceland, June 28, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the US Food and Drug Administration …

Distribution channels: Companies, Technology ...

Published on June 12, 2023 - 07:00 GMT

Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025 REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech ( …

Distribution channels: Companies, Science ...

Published on May 31, 2023 - 15:30 GMT

HEMPE Announced as Master Sponsor of 2023 World Strength Games & Adaptive Strength Championships

HEMPE sponsor 2023 World Strength Games and Adaptive Strength World Championships, promoting natural natural pain relief alternatives and supporting athletes. WIMBORNE, DORSET, UNITED KINGDOM, May 31, 2023 /⁨EINPresswire.com⁩/ -- HEMPE Announced as Master …

Distribution channels: Beauty & Hair Care, Consumer Goods ...

Published on May 31, 2023 - 09:20 GMT

Alvotech to Participate in Jefferies Healthcare Conference

REYKJAVIK, Iceland, May 31, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Jefferies …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on May 24, 2023 - 09:00 GMT

Alvotech and Advanz Pharma extend strategic partnership to commercialize five proposed biosimilars in Europe

Advanz Pharma secures exclusive rights from Alvotech to commercialize five proposed biosimilars in Europe The agreement includes proposed biosimilars to Simponi® (golimumab), Entyvio® (vedolizumab) and three additional early-stage undisclosed biosimilar …

Distribution channels: Companies, Technology ...

Published on May 19, 2023 - 09:00 GMT

Alvotech Reports Financial Results for First three Months of 2023 and Provides Business Update

Revenue for the first three months of 2023 increased to $15.9 million, compared to $0.8 million for the same period in 2022 Confirmatory patient study for AVT05, a proposed biosimilar for Simponi® and Simponi Aria® (golimumab) initiated, marking the fifth …

Distribution channels: Business & Economy, Technology ...

Published on May 17, 2023 - 09:00 GMT

Alvotech to Participate in Morgan Stanley Annual Sustainable Finance Summit

REYKJAVIK, Iceland, May 17, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Morgan Stanley …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on May 15, 2023 - 09:00 GMT

Alvotech Issues Annual Equality Report Covering 2022

Alvotech’s global workforce is now evenly split between females and males, and the unexplained gender pay gap has been reduced to 1.6% from 5.2% in December 2020 Alvotech’s Equality Policy, which is based on Icelandic law, has been implemented for the …

Distribution channels: Business & Economy, Technology ...

Published on May 10, 2023 - 09:00 GMT

Alvotech enters into commercialization agreement with Polifarma for proposed biosimilar to Eylea® (aflibercept)

Polifarma will commercialize AVT06, a proposed biosimilar to Eylea® (aflibercept), in Turkey REYKJAVIK, Iceland, May 10, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of …

Distribution channels: Companies, Technology ...

Published on May 4, 2023 - 09:00 GMT

Alvotech Initiates Confirmatory Patient Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®

The clinical study will compare AVT05 and Simponi® in patients with moderate to severe rheumatoid arthritis REYKJAVIK, Iceland, May 04, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and …

Distribution channels: Technology

Published on May 3, 2023 - 13:00 GMT

Alvotech to Report First Quarter 2023 Financial Results and Recent Business Highlights on May 18, 2023 and Host Conference Call on ...

REYKJAVIK, Iceland, May 03, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results for …

Distribution channels: Technology

Published on April 19, 2023 - 21:30 GMT

Sarah Tanksley Joins Board of Directors for Alvotech hf. and Sandra Casaca Appointed Chief Quality Officer

REYKJAVIK, Iceland, April 19, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced changes to the company’s Quality unit. …

Distribution channels: Companies, Technology ...

Published on April 14, 2023 - 00:45 GMT

Alvotech Provides Regulatory Update on AVT02 Biologics License Application

REYKJAVIK, Iceland, April 14, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the U.S. Food and Drug …

Distribution channels: Media, Advertising & PR, Technology ...

Iceland Press Releases Distributed by EIN Presswire